GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an ...

Adults in their seventies who had unexplained weight loss were more likely to be diagnosed ... healthy weight in midlife is protective, reducing the risk of diabetes and vascular diseases, which ...

Ozempic is medicine for adults with type 2 diabetes that ... safety profile of weight-loss drugs, which have previously been linked to very rare but concerning potential risk of suicidal thoughts ...

They found that those taking the popular weight loss drugs, also known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), had a lower risk of stroke, a heart attack, substance use disorders ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

Blockbuster weight loss drugs ... or type 2 diabetes and work by suppressing people’s appetites to help them lose weight. That includes a 12 per cent reduction in the risk of Alzheimer’s ...

On the flip side, researchers found use of the diabetes and weight loss drugs increased the risk of joint pain, inflammation in the pancreas, low blood pressure, fainting, headaches, kidney stones ...

Weight-loss drugs such ... such as lowering the risk of stroke and dementia. Researchers used US Department of Veterans Affairs data to find people with diabetes who used drugs containing GLP ...